Value of intraoperative parathyroid hormone monitoring

Jyotirmay Sharma, Kresimira Milas, Eren Berber, Peter Mazzaglia, Alan Siperstein, Collin J. Weber

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background: Routine use of intraoperative parathyroid hormone (IOPTH) has been challenged in both unilateral/limited (LE) and bilateral exploration (BE). To investigate this, we assessed the usefulness of IOPTH in surgical management of primary hyperparathyroidism and parathyroid carcinoma (PC). Methods: Between 1998 and 2006, 1133 patients were explored for hyperparathyroidism: 185 LE, 743 BE with IOPTH, 95 BE without IOPTH, 110 reoperations, and 4 PCs. IOPTH patterns were correlated with parathyroid pathology (single adenoma [SA] or multigland disease [MGD]) and operative success. Results: In LE, IOPTH returned to normal in 78% of patients; all patients had SA, and 99% were cured at a mean ± SEM of 1.2 ± .24 years; 22% of LE patients (n = 41) whose IOPTH did not return to normal were converted to BE, and all had MGD. BE with and without IOPTH was equally successful 97% and 98% (P = NS) of the time, respectively. In BE in which IOPTH did not return to normal, 9% of patients remained hypercalcemic; tumor distribution mirrored other BE patients (75% SA, 25% MGD). In reoperations, a normal final IOPTH correlated with cure in 99%; otherwise, 59% had persistent disease. Differential bilateral internal jugular vein IOPTH sampling lateralized disease in 77% of reoperations. Conclusions: IOPTH is an important adjunct for successful LE by identifying the presence of MGD and avoiding operative failure. IOPTH adds little to BE; however, final IOPTH values may predict persistent disease in BE, reoperations, and PCs.

Original languageEnglish (US)
Pages (from-to)493-498
Number of pages6
JournalAnnals of Surgical Oncology
Volume15
Issue number2
DOIs
StatePublished - Feb 2008
Externally publishedYes

Fingerprint

Parathyroid Hormone
Reoperation
Adenoma
Parathyroid Neoplasms
Primary Hyperparathyroidism
Hyperparathyroidism
Jugular Veins

Keywords

  • Hyperparathyroidism
  • Intraoperative Parathyroid Hormone
  • Minimally invasive parathyrodectomy
  • Parathyroid Hormone Kinetics
  • Parathyroidectomy
  • Reoperative Parathyroidectomy

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Sharma, J., Milas, K., Berber, E., Mazzaglia, P., Siperstein, A., & Weber, C. J. (2008). Value of intraoperative parathyroid hormone monitoring. Annals of Surgical Oncology, 15(2), 493-498. https://doi.org/10.1245/s10434-007-9683-2

Value of intraoperative parathyroid hormone monitoring. / Sharma, Jyotirmay; Milas, Kresimira; Berber, Eren; Mazzaglia, Peter; Siperstein, Alan; Weber, Collin J.

In: Annals of Surgical Oncology, Vol. 15, No. 2, 02.2008, p. 493-498.

Research output: Contribution to journalArticle

Sharma, J, Milas, K, Berber, E, Mazzaglia, P, Siperstein, A & Weber, CJ 2008, 'Value of intraoperative parathyroid hormone monitoring', Annals of Surgical Oncology, vol. 15, no. 2, pp. 493-498. https://doi.org/10.1245/s10434-007-9683-2
Sharma J, Milas K, Berber E, Mazzaglia P, Siperstein A, Weber CJ. Value of intraoperative parathyroid hormone monitoring. Annals of Surgical Oncology. 2008 Feb;15(2):493-498. https://doi.org/10.1245/s10434-007-9683-2
Sharma, Jyotirmay ; Milas, Kresimira ; Berber, Eren ; Mazzaglia, Peter ; Siperstein, Alan ; Weber, Collin J. / Value of intraoperative parathyroid hormone monitoring. In: Annals of Surgical Oncology. 2008 ; Vol. 15, No. 2. pp. 493-498.
@article{41b4b2a2e93d4cc7bb1b4d4f2070125b,
title = "Value of intraoperative parathyroid hormone monitoring",
abstract = "Background: Routine use of intraoperative parathyroid hormone (IOPTH) has been challenged in both unilateral/limited (LE) and bilateral exploration (BE). To investigate this, we assessed the usefulness of IOPTH in surgical management of primary hyperparathyroidism and parathyroid carcinoma (PC). Methods: Between 1998 and 2006, 1133 patients were explored for hyperparathyroidism: 185 LE, 743 BE with IOPTH, 95 BE without IOPTH, 110 reoperations, and 4 PCs. IOPTH patterns were correlated with parathyroid pathology (single adenoma [SA] or multigland disease [MGD]) and operative success. Results: In LE, IOPTH returned to normal in 78{\%} of patients; all patients had SA, and 99{\%} were cured at a mean ± SEM of 1.2 ± .24 years; 22{\%} of LE patients (n = 41) whose IOPTH did not return to normal were converted to BE, and all had MGD. BE with and without IOPTH was equally successful 97{\%} and 98{\%} (P = NS) of the time, respectively. In BE in which IOPTH did not return to normal, 9{\%} of patients remained hypercalcemic; tumor distribution mirrored other BE patients (75{\%} SA, 25{\%} MGD). In reoperations, a normal final IOPTH correlated with cure in 99{\%}; otherwise, 59{\%} had persistent disease. Differential bilateral internal jugular vein IOPTH sampling lateralized disease in 77{\%} of reoperations. Conclusions: IOPTH is an important adjunct for successful LE by identifying the presence of MGD and avoiding operative failure. IOPTH adds little to BE; however, final IOPTH values may predict persistent disease in BE, reoperations, and PCs.",
keywords = "Hyperparathyroidism, Intraoperative Parathyroid Hormone, Minimally invasive parathyrodectomy, Parathyroid Hormone Kinetics, Parathyroidectomy, Reoperative Parathyroidectomy",
author = "Jyotirmay Sharma and Kresimira Milas and Eren Berber and Peter Mazzaglia and Alan Siperstein and Weber, {Collin J.}",
year = "2008",
month = "2",
doi = "10.1245/s10434-007-9683-2",
language = "English (US)",
volume = "15",
pages = "493--498",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Value of intraoperative parathyroid hormone monitoring

AU - Sharma, Jyotirmay

AU - Milas, Kresimira

AU - Berber, Eren

AU - Mazzaglia, Peter

AU - Siperstein, Alan

AU - Weber, Collin J.

PY - 2008/2

Y1 - 2008/2

N2 - Background: Routine use of intraoperative parathyroid hormone (IOPTH) has been challenged in both unilateral/limited (LE) and bilateral exploration (BE). To investigate this, we assessed the usefulness of IOPTH in surgical management of primary hyperparathyroidism and parathyroid carcinoma (PC). Methods: Between 1998 and 2006, 1133 patients were explored for hyperparathyroidism: 185 LE, 743 BE with IOPTH, 95 BE without IOPTH, 110 reoperations, and 4 PCs. IOPTH patterns were correlated with parathyroid pathology (single adenoma [SA] or multigland disease [MGD]) and operative success. Results: In LE, IOPTH returned to normal in 78% of patients; all patients had SA, and 99% were cured at a mean ± SEM of 1.2 ± .24 years; 22% of LE patients (n = 41) whose IOPTH did not return to normal were converted to BE, and all had MGD. BE with and without IOPTH was equally successful 97% and 98% (P = NS) of the time, respectively. In BE in which IOPTH did not return to normal, 9% of patients remained hypercalcemic; tumor distribution mirrored other BE patients (75% SA, 25% MGD). In reoperations, a normal final IOPTH correlated with cure in 99%; otherwise, 59% had persistent disease. Differential bilateral internal jugular vein IOPTH sampling lateralized disease in 77% of reoperations. Conclusions: IOPTH is an important adjunct for successful LE by identifying the presence of MGD and avoiding operative failure. IOPTH adds little to BE; however, final IOPTH values may predict persistent disease in BE, reoperations, and PCs.

AB - Background: Routine use of intraoperative parathyroid hormone (IOPTH) has been challenged in both unilateral/limited (LE) and bilateral exploration (BE). To investigate this, we assessed the usefulness of IOPTH in surgical management of primary hyperparathyroidism and parathyroid carcinoma (PC). Methods: Between 1998 and 2006, 1133 patients were explored for hyperparathyroidism: 185 LE, 743 BE with IOPTH, 95 BE without IOPTH, 110 reoperations, and 4 PCs. IOPTH patterns were correlated with parathyroid pathology (single adenoma [SA] or multigland disease [MGD]) and operative success. Results: In LE, IOPTH returned to normal in 78% of patients; all patients had SA, and 99% were cured at a mean ± SEM of 1.2 ± .24 years; 22% of LE patients (n = 41) whose IOPTH did not return to normal were converted to BE, and all had MGD. BE with and without IOPTH was equally successful 97% and 98% (P = NS) of the time, respectively. In BE in which IOPTH did not return to normal, 9% of patients remained hypercalcemic; tumor distribution mirrored other BE patients (75% SA, 25% MGD). In reoperations, a normal final IOPTH correlated with cure in 99%; otherwise, 59% had persistent disease. Differential bilateral internal jugular vein IOPTH sampling lateralized disease in 77% of reoperations. Conclusions: IOPTH is an important adjunct for successful LE by identifying the presence of MGD and avoiding operative failure. IOPTH adds little to BE; however, final IOPTH values may predict persistent disease in BE, reoperations, and PCs.

KW - Hyperparathyroidism

KW - Intraoperative Parathyroid Hormone

KW - Minimally invasive parathyrodectomy

KW - Parathyroid Hormone Kinetics

KW - Parathyroidectomy

KW - Reoperative Parathyroidectomy

UR - http://www.scopus.com/inward/record.url?scp=40649098638&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40649098638&partnerID=8YFLogxK

U2 - 10.1245/s10434-007-9683-2

DO - 10.1245/s10434-007-9683-2

M3 - Article

VL - 15

SP - 493

EP - 498

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 2

ER -